Vitamin Shoppe, Inc. - FORM 10-Q

Vitamin Shoppe, Inc. - FORM 10-Q - August 3, 2016

Attached files

Attached files

Vitamin Shoppe, Inc. Reports

file	filename
EX-32.2 - EXHIBIT 32.2 - Vitamin Shoppe, Inc.	vsi-06252016x10qxex322.htm
EX-32.1 - EXHIBIT 32.1 - Vitamin Shoppe, Inc.	vsi-06252016x10qxex321.htm
EX-31.2 - EXHIBIT 31.2 - Vitamin Shoppe, Inc.	vsi-06252016x10qxex312.htm
EX-31.1 - EXHIBIT 31.1 - Vitamin Shoppe, Inc.	vsi-06252016x10qxex311.htm

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

_________________________________________________________________________________________

FORM 10-Q

_________________________________________________________________________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 25, 2016



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from to .

Commission file number: 001-34507

_________________________________________________________________________________________

VITAMIN SHOPPE, INC.

(Exact name of registrant as specified in its charter)

________________________________________________________________________________________



Delaware		11-3664322
(State or Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)

300 Harmon Meadow Blvd.

Secaucus, New Jersey 07094

(Addresses of Principal Executive Offices, including Zip Code)

(201) 868-5959

(Registrant’s Telephone Number, Including Area Code)

_________________________________________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ¨ No x

As of July 15, 2016 Vitamin Shoppe, Inc. had 24,000,924 shares of common stock outstanding.

Table of Contents

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding future financial results and performance, future business prospects, revenue, stores, our ability to implement strategic initiatives, realize improved financial results and meet market expectations, our ability to identify efficiencies and cost reduction opportunities, share repurchases, product offerings, contract manufacturing, supply chain network utilization, intellectual property, integration of acquisitions, working capital, liquidity, capital expenditures, capital needs and interest costs, industry based factors, including the level of competition in the vitamin, mineral and supplement industry, continued demand from the primary markets Vitamin Shoppe, Inc. (the “Company” or “we”) serves, consumer perception of our products, the availability of raw materials, as well as economic conditions generally and factors more specific to the Company such as compliance with manufacturing, healthcare, environmental and other regulations, changes in accounting standards, certifications and practices and restrictions imposed by the Company’s Revolving Credit Facility (as defined below), including financial covenants and limitations on the Company’s ability to incur additional indebtedness and the Company’s future capital requirements, and other risks, uncertainties and factors set forth under Item 1A., entitled “Risk Factors”, in the Company’s Annual Report on Form 10-K for the fiscal year ended December 26, 2015 and in our other reports and documents filed with the Securities and Exchange Commission (the “SEC”). You can identify these forward-looking statements by the use of words such as “outlook”, “believes”, “expects”, “potential”, “continues”, “may”, “will”, “should”, “seeks”, “predicts”, “intends”, “plans”, “estimates”, “anticipates”, “target”, “could” or the negative version of these words or other comparable words. These statements are subject to various risks and uncertainties, many of which are outside our control, including, among others, product liability claims and recalls, the availability of insurance, the strength of the economy, changes in the overall level of consumer spending, the performance of the Company's products within the prevailing retail environment, trade restrictions, international operations, availability of suitable store locations at appropriate terms, new credit card technology, e-commerce relationships, disruptions of manufacturing, warehouse or distribution facilities or information systems, and other specific factors discussed herein and in other SEC filings by us (including our reports on Forms 10-K and 10-Q filed with the SEC).

We believe that all forward-looking statements are based on reasonable assumptions when made; however, we caution that it is impossible to predict actual results or outcomes or the effects of risks, uncertainties or other factors on anticipated results or outcomes with certainty and that, accordingly, one should not place undue reliance on these statements. Forward-looking statements speak only as of the date when made and we undertake no obligation to update these statements in light of subsequent events or developments. Actual results may differ materially from anticipated results or outcomes discussed in any forward-looking statement.

Table of Contents

TABLE OF CONTENTS



		Page No.
	PART I. FINANCIAL INFORMATION	4
Item 1.	Financial Statements	4
	Condensed Consolidated Balance Sheets (unaudited) as of June 25, 2016 and December 26, 2015	4
	Condensed Consolidated Statements of Income (unaudited) for the three and six months ended June 25, 2016 and June 27, 2015	5
	Condensed Consolidated Statements of Comprehensive Income (unaudited) for the three and six months ended June 25, 2016 and June 27, 2015	5
	Condensed Consolidated Statements of Cash Flows (unaudited) for the six months ended June 25, 2016 and June 27, 2015	6
	Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28

	PART II. OTHER INFORMATION	30
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 3.	Defaults Upon Senior Securities	30
Item 4.	Mine Safety Disclosures	30
Item 5.	Other Information	30
Item 6.	Exhibits	31

Signature		32

EX 31.1
EX 31.2
EX 32.1
EX 32.2
EX-101	INSTANCE DOCUMENT
EX-101	SCHEMA DOCUMENT
EX-101	CALCULATION LINKBASE DOCUMENT
EX-101	DEFINITION LINKBASE DOCUMENT
EX-101	LABELS LINKBASE DOCUMENT
EX-101	PRESENTATION LINKBASE DOCUMENT

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)



	June 25, 2016			December 26, 2015
ASSETS
Current assets:
Cash and cash equivalents	$	1,992		$	15,104
Accounts receivable, net of allowance of $941 and $897 in 2016 and 2015, respectively	5,381			7,437
Inventories	230,256			226,830
Prepaid expenses and other current assets	30,636			25,194
Total current assets	268,265			274,565
Property and equipment, net of accumulated depreciation and amortization of $288,110 and $274,222 in 2016 and 2015, respectively	139,769			140,158
Goodwill	243,269			243,269
Other intangibles, net	86,623			87,270
Other assets	2,606			3,429
Total assets	$	740,532		$	748,691
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Revolving credit facility	$	15,000		$	8,000
Accounts payable	56,151			41,217
Accrued expenses and other current liabilities	58,187			68,259
Total current liabilities	129,338			117,476
Convertible notes, net	118,067			115,410
Deferred rent	38,921			39,889
Other long-term liabilities	1,901			615
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued and outstanding at June 25, 2016 and December 26, 2015	—			—
Common stock, $0.01 par value; 400,000,000 shares authorized, 24,125,183 shares issued and 23,972,349 shares outstanding at June 25, 2016, and 25,993,715 shares issued and 25,873,581 shares outstanding at December 26, 2015	241			260
Additional paid-in capital	92,549			139,827
Treasury stock, at cost; 152,834 shares at June 25, 2016 and 120,134 shares at December 26, 2015	(6,199		)	(5,225		)
Accumulated other comprehensive loss	—			(60		)
Retained earnings	365,714			340,499
Total stockholders’ equity	452,305			475,301
Total liabilities and stockholders’ equity	$	740,532		$	748,691

See accompanying notes to condensed consolidated financial statements.

Table of Contents

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except share and per share data)

(Unaudited)



	Three Months Ended				Six Months Ended
	June 25, 2016		June 27, 2015		June 25, 2016		June 27, 2015
Net sales	$	332,717	$	322,338	$	669,491	$	659,173
Cost of goods sold	224,893		214,078		445,420		436,264
Gross profit	107,824		108,260		224,071		222,909
Selling, general and administrative expenses	87,100		84,696		176,085		168,390
Income from operations	20,724		23,564		47,986		54,519
Interest expense, net	2,352		179		4,614		343
Income before provision for income taxes	18,372		23,385		43,372		54,176
Provision for income taxes	7,939		9,144		18,157		21,235
Net income	$	10,433	$	14,241	$	25,215	$	32,941
Weighted average common shares outstanding
Basic	23,763,934		29,230,046		24,283,135		29,363,823
Diluted	23,938,978		29,455,455		24,474,018		29,661,400
Net income per common share
Basic	$	0.44	$	0.49	$	1.04	$	1.12
Diluted	$	0.44	$	0.48	$	1.03	$	1.11

See accompanying notes to condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)



	Three Months Ended					Six Months Ended
	June 25, 2016		June 27, 2015			June 25, 2016		June 27, 2015
Net income	$	10,433	$	14,241		$	25,215	$	32,941
Other comprehensive income (loss):
Foreign currency translation adjustments	149		(34		)	60		59
Other comprehensive income (loss)	149		(34		)	60		59
Comprehensive income	$	10,582	$	14,207		$	25,275	$	33,000

See accompanying notes to condensed consolidated financial statements.

Table of Contents

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



	Six Months Ended
	June 25, 2016			June 27, 2015
Cash flows from operating activities:
Net income	$	25,215		$	32,941
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets	19,440			18,750
Impairment charges on fixed assets	218			321
Amortization of deferred financing fees	472			79
Amortization of debt discount on convertible notes	2,278			—
Deferred income taxes	1,899			2,344
Deferred rent	(1,546		)	(1,130		)
Equity compensation expense	3,534			3,486
Issuance of shares for services rendered	333			—
Tax benefits on exercises of equity awards	577			(45		)
Contingent consideration for acquisition of FDC Vitamins, LLC	—			(959		)
Changes in operating assets and liabilities:
Accounts receivable	2,056			3,947
Inventories	(2,538		)	(23,658		)
Prepaid expenses and other current assets	(5,441		)	1,900
Other long-term assets	81			(217		)
Accounts payable	16,879			2,148
Accrued expenses and other current liabilities	(9,077		)	(9,250		)
Other long-term liabilities	561			1,114
Net cash provided by operating activities	54,941			31,771
Cash flows from investing activities:
Capital expenditures	(21,005		)	(20,526		)
Acquisition of FDC Vitamins, LLC	—			487
Trademarks and other intangible assets	(171		)	(307		)
Net cash used in investing activities	(21,176		)	(20,346		)
Cash flows from financing activities:
Borrowings under revolving credit facility	35,000			27,000
Repayments of borrowings under revolving credit facility	(28,000		)	(17,000		)
Bank overdraft	(1,663		)	—
Contingent consideration payment for acquisition of FDC Vitamins, LLC	—			(4,041		)
Proceeds from exercises of common stock options	7			1,004
Issuance of shares under employee stock purchase plan	342			509
Tax benefits on exercises of equity awards	(577		)	45
Purchases of treasury stock	(974		)	(2,280		)
Purchases of shares under Share Repurchase Programs	(51,011		)	(25,541		)
Other financing activities	(54		)	(61		)
Net cash used in financing activities	(46,930		)	(20,365		)
Effect of exchange rate changes on cash and cash equivalents	53			103
Net decrease in cash and cash equivalents	(13,112		)	(8,837		)

Table of Contents



Cash and cash equivalents beginning of period	15,104		12,166
Cash and cash equivalents end of period	$	1,992	$	3,329
Supplemental disclosures of cash flow information:
Interest paid	$	1,738	$	180
Income taxes paid	$	21,661	$	16,645
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment	$	5,774	$	5,314

See accompanying notes to condensed consolidated financial statements.

Table of Contents

VITAMIN SHOPPE, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Basis of Presentation

Vitamin Shoppe, Inc. (“VSI”), is incorporated in the State of Delaware, and through its wholly-owned subsidiary, Vitamin Shoppe Industries Inc. (“Subsidiary” or “Industries” together with VSI, the “Company”), is a multi-channel specialty retailer and contract manufacturer of nutritional products. Sales of both national brands and our own brands of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products (“VMS products”) are made through VSI-operated retail stores and the internet to customers located primarily in the United States. The Company manufactures products for both sales to third parties as well as for the VSI product assortment.

The condensed consolidated financial statements as of June 25, 2016 and June 27, 2015 are unaudited. The condensed consolidated balance sheet as of December 26, 2015 was derived from our audited financial statements. All intercompany transactions and balances have been eliminated in consolidation. In addition, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted. The interim financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation in conformity with GAAP. The interim financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K for the fiscal year ended December 26, 2015, as filed with the Securities and Exchange Commission on February 23, 2016 (the “Fiscal 2015 Form 10-K”). The results of operations for the interim periods should not be considered indicative of results to be expected for the full year.

The Company's fiscal year ends on the last Saturday in December. As used herein, the term "Fiscal Year" or "Fiscal" refers to a 52-week or 53-week period, ending on the last Saturday in December. Fiscal 2016 is a 53-week fiscal year. The results for the three and six months ended June 25, 2016 and June 27, 2015 are each based on 13-week and 26-week periods, respectively.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements, and revenue and expenses during the reporting period. Actual results could differ from those estimates.

Except as noted below, the Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on its results of operations, financial condition, or cash flows, based on current information.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of ASU 2014-09 by one year. ASU 2014-09 will be effective for annual reporting periods beginning after December 15, 2017 for public companies and early adoption of ASU 2014-09 is permitted for public companies for annual reporting periods beginning after December 15, 2016. The Company is evaluating ASU 2014-09 to determine which transition approach it will utilize and if this guidance will have a material impact on the Company’s condensed consolidated financial statements.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11 (“ASU 2015-11”), Simplifying the Measurement of Inventory (Topic 330). ASU 2015-11 simplifies the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. ASU 2015-11 is effective for public companies for annual reporting periods beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption of ASU 2015-11 is permitted. The Company is evaluating ASU 2015-11 to determine if this guidance will have a material impact on the Company’s condensed consolidated financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (“ASU 2016-02”), Leases (Topic 842). ASU 2016-02 was issued by the FASB to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. ASU 2016-02 will require modified retrospective application at the beginning of our first quarter of Fiscal 2019, but permits adoption in an earlier period. The Company is evaluating ASU 2016-02 in order to determine the impact of this guidance on the Company’s condensed consolidated financial statements and

Table of Contents

anticipates this guidance will significantly impact our condensed consolidated financial statements given we have a significant number of leases.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09 (“ASU 2016-09”), Compensation-Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 addresses simplification of several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for public companies for annual reporting periods beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption of ASU 2016-09 is permitted. The Company is evaluating ASU 2016-09 to determine if this guidance will have a material impact on the Company’s condensed consolidated financial statements.

2. Inventories

The components of inventories are as follows (in thousands):



	June 25, 2016		December 26, 2015
Finished goods	$	209,522	$	211,879
Work-in-process	7,139		6,180
Raw materials	13,595		8,771
	$	230,256	$	226,830

3. Goodwill and Intangible Assets

Goodwill is allocated between the Company’s segments (reporting units), retail, direct and manufacturing. The following table discloses the carrying value of all intangible assets (in thousands):



	June 25, 2016						December 26, 2015
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets
Goodwill	$	243,269	$	—	$	243,269	$	243,269	$	—	$	243,269
Tradenames – Indefinite-lived	68,405		—		68,405		68,405		—		68,405
Brands	10,000		1,157		8,843		10,000		880		9,120
Customer relationships	7,500		781		6,719		7,500		594		6,906
Tradenames – Definite-lived	4,844		2,946		1,898		4,673		2,722		1,951
Software	1,300		542		758		1,300		412		888
	$	335,318	$	5,426	$	329,892	$	335,147	$	4,608	$	330,539

Table of Contents

The useful lives of the Company’s definite-lived intangible assets are between 3 to 20 years. The expected amortization expense on definite-lived intangible assets on the Company’s condensed consolidated balance sheet at June 25, 2016, is as follows (in thousands):




Remainder of Fiscal 2016	$	715
Fiscal 2017	1,430
Fiscal 2018	1,430
Fiscal 2019	1,430
Fiscal 2020	1,430
Thereafter	11,783
	$	18,218

4. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):



	June 25, 2016		December 26, 2015
Accrued salaries and related expenses	$	10,781	$	10,115
Sales tax payable and related expenses	6,857		6,975
Deferred sales (a)	5,969		20,483
Accrued fixed asset additions	4,332		5,842
Other accrued expenses	30,248		24,844
	$	58,187	$	68,259

(a) The reduction in deferred sales reflects the change in the Company's loyalty program from annual redemptions to quarterly redemptions beginning in Fiscal 2016.

5. Credit Arrangements

Convertible Senior Notes due 2020

On December 9, 2015, the Company issued $143.8 million of its 2.25% Convertible Senior Notes due 2020 (the “Convertible Notes”). The Convertible Notes are senior unsecured obligations of VSI. Interest on the Convertible Notes is payable on June 1 and December 1 of each year, commencing on June 1, 2016 until their maturity date of December 1, 2020. The Company may not redeem the Convertible Notes prior to the maturity date.

Prior to July 1, 2020, the Convertible Notes will be convertible only under certain circumstances. The Convertible Notes will be convertible at an initial conversion rate of 25.1625 shares of the Company’s common stock per $1,000 principal amount of the Convertible Notes, which is equivalent to an initial conversion price of approximately $39.74. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, the Company is required to increase, in certain circumstances, the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event including customary conversion rate adjustments in connection with a “make-whole fundamental change” as defined. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at its election.

The Company allocated the principal amount of the Convertible Notes between its liability and equity components (see table below). The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument of similar credit quality and maturity that did not have the conversion feature. The carrying amount of the equity

Table of Contents

component, representing the embedded conversion option, was determined by deducting the fair value of the liability component from the principal amount of the Convertible Notes as a whole. The equity component was recorded to additional paid-in capital and is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the Convertible Notes over the carrying amount of the liability component was recorded as a debt discount, and is being amortized to interest expense using an effective interest rate of 3.8% over the term of the Convertible Notes. The Company allocated the total amount of transaction costs incurred to the liability and equity components using the same proportions as the proceeds from the Convertible Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the liability component of the Convertible Notes, and are being amortized to interest expense using the effective interest method through the maturity date. Transaction costs attributable to the equity component were netted with the equity component of the Convertible Notes in additional paid-in capital.

The Convertible Notes consist of the following components (in thousands):



	June 25, 2016			December 26, 2015
Liability component:
Principal	$	143,750		$	143,750
Conversion feature	(24,800		)	(24,800		)
Liability portion of debt issuance costs	(3,802		)	(3,800		)
Amortization	2,919			260
Net carrying amount	$	118,067		$	115,410

Equity component:
Conversion feature	$	24,800		$	24,800
Equity portion of debt issuance costs	(793		)	(793		)
Deferred taxes	941			941
Net carrying amount	$	24,948		$	24,948

In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions for which it paid an aggregate $26.4 million. In addition, the Company sold warrants for which it received aggregate proceeds of $13.0 million. The convertible note hedge transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted notes. However, the warrant transaction could separately have a dilutive effect to the extent that the market value per share of the Company’s common stock exceeds the applicable strike price of the warrant transactions, which is approximately $52.99 at inception. As these transactions meet certain accounting criteria, the convertible note hedge and warrant transactions are recorded in stockholders’ equity, are not accounted for as derivatives and are not remeasured each reporting period.

The net proceeds from the Convertible Notes and related transactions of $125.7 million, net of commissions and offering costs of $4.6 million, were used to repurchase shares of the Company’s common stock under the Company’s share repurchase programs. Refer to Note 9. Share Repurchase Programs for additional information.

Revolving Credit Facility

As of June 25, 2016 and December 26, 2015, the Company had $15.0 million and $8.0 million of borrowings outstanding on its Revolving Credit Facility (the "Revolving Credit Facility"), respectively.

Subject to the terms of the Revolving Credit Facility, which has a maturity date of October 11, 2018, the Company may borrow up to $90.0 million, with a Company option to increase the facility up to a total of $150.0 million. The availability under the Revolving Credit Facility is subject to a borrowing base calculated on the value of certain accounts receivable as well as certain inventory of the Company. The obligations thereunder are secured by a security interest in substantially all of the assets of the Company. Under the Revolving Credit Facility, VSI has guaranteed the Company’s obligations, and Industries and its wholly-owned subsidiaries have each guaranteed the obligations of the other respective entities. The Revolving Credit Facility provides for affirmative and negative covenants affecting the Company. The Revolving Credit Facility restricts, among

Table of Contents

other things, the Company’s ability to incur indebtedness, create or permit liens on the Company’s assets, declare or pay dividends and make certain other restricted payments, consolidate, merge or recapitalize, sell assets, make certain investments, loans or other advances, enter into transactions with affiliates, change our line of business, and restricts the types of hedging activities the Company can enter into. The largest amount outstanding during the six months ended June 25, 2016 and June 27, 2015 was $21.0 million and $27.0 million, respectively. The unused available line of credit under the Revolving Credit Facility at June 25, 2016 was $72.1 million.

Borrowings under the Revolving Credit Facility accrue interest, at the Company’s option, at the rate per annum based on an “alternative base rate” plus 0.25% or 0.50% or the adjusted Eurodollar rate plus 1.25% or 1.50%, in each case with the higher spread applicable in the event that the aggregate amount of the borrowings under the Revolving Credit Facility exceeds 50% of the borrowing base availability under the Revolving Credit Facility. The weighted average interest rate for the Revolving Credit Facility during the six months ended June 25, 2016 and June 27, 2015 was 1.74% and 1.44%, respectively. The commitment fee on the undrawn portion of the $90.0 million Revolving Credit Facility was 0.25% as of June 25, 2016 and December 26, 2015.

Interest expense, net for the three and six months ended June 25, 2016 and June 27, 2015 consists of the following (in thousands):



	Three Months Ended					Six Months Ended
	June 25, 2016		June 27, 2015			June 25, 2016		June 27, 2015
Amortization of debt discount on convertible notes	$	1,144	$	—		$	2,278	$	—
Interest on convertible notes	833		—			1,637		—
Amortization of deferred financing fees	235		40			472		79
Interest / fees on the revolving credit facility and other interest	140		140			227		265
Interest income	—		(1		)	—		(1		)
Interest expense, net	$	2,352	$	179		$	4,614	$	343

6. Stock Based Compensation

Equity Incentive Plans – The Company has two equity incentive plans that provide stock based compensation to certain directors, officers, consultants and employees of the Company; the 2006 Stock Option Plan (the “2006 Plan”) and the Vitamin Shoppe 2009 Equity Incentive Plan (the “2009 Plan”). As of June 25, 2016, there were 2,106,138 shares available to grant under both plans which includes 152,834 shares currently held by the Company as treasury stock.

The following table summarizes restricted shares for the 2009 Plan as of June 25, 2016 and changes during the six month period then ended:



	Number of Unvested Restricted Shares		Weighted Average Grant Date Fair Value
Unvested at December 26, 2015	398,562		$	42.65
Granted	137,242		$	30.11
Vested	(83,275	)	$	46.84
Canceled/forfeited	(64,931	)	$	44.79
Unvested at June 25, 2016	387,598		$	36.95

The total intrinsic value of restricted shares vested during the six months ended June 25, 2016 and June 27, 2015, was $2.5 million and $5.6 million, respectively.

The following table summarizes stock options for the 2006 and 2009 Plans as of June 25, 2016 and changes during the six month period then ended:

Table of Contents



	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 26, 2015	284,838		$	22.65
Granted	217,369		$	30.25
Exercised	(558	)	$	13.43
Canceled/forfeited	(11,133	)	$	34.19
Outstanding at June 25, 2016	490,516		$	25.76	5.50	$	2,749
Vested or expected to vest at June 25, 2016	475,253		$	25.76	5.50
Vested and exercisable at June 25, 2016	270,647		$	21.89	2.12	$	2,746

The total intrinsic value of options exercised during the six months ended June 25, 2016 was de minimis and during the six months ended June 27, 2015 was $0.8 million. The cash received from options exercised during the six months ended June 25, 2016 was de minimis and during the six months ended June 27, 2015 was $1.0 million.

Stock options granted during the six months ended June 25, 2016 shall become vested in equal installments on the first, second and third anniversaries of the date on which such equity grants were awarded.

The following table summarizes performance share units for the 2009 Plan as of June 25, 2016 and changes during the six month period then ended:



	Number of Unvested Performance Share Units	Weighted Average Grant Date Fair Value
Unvested at December 26, 2015	—	$	—
Granted	119,155	$	30.25
Vested	—	$	—
Canceled/forfeited	—	$	—
Unvested at June 25, 2016	119,155	$	30.25

Performance share units granted during the six months ended June 25, 2016 shall become vested on December 29, 2018 if the performance criteria are achieved. Performance share units can vest at a range of 25% to 150% based on the achievement of pre-established performance targets.

The following table summarizes restricted share units for the 2009 Plan as of June 25, 2016 and changes during the six month period then ended:



	Number of Unvested Restricted Share Units		Weighted Average Grant Date Fair Value
Unvested at December 26, 2015	11,280		$	37.25
Granted	940		$	29.98
Vested	(8,460	)	$	37.25
Canceled/forfeited	—		$	—
Unvested at June 25, 2016	3,760		$	35.43

The total intrinsic value of restricted share units vested during the six months ended June 25, 2016 and June 27, 2015, was $0.3 million and $0.5 million, respectively.

Compensation expense attributable to stock based compensation for the three and six months ended June 25, 2016 was approximately $1.8 million and $3.5 million, respectively, and for the three and six months ended June 27, 2015 was approximately $1.3 million and $3.5 million, respectively. As of June 25, 2016, the remaining unrecognized stock based compensation expense for non-vested stock options, restricted shares, performance share units and restricted share units to be

Table of Contents

expensed in future periods is $11.1 million, and the related weighted-average period over which it is expected to be recognized is 2.0 years. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its historical forfeiture rate since the inception of granting stock based awards. The estimated value of future forfeitures for stock options, restricted shares, performance share units and restricted share units as of June 25, 2016 is approximately $1.0 million.

The weighted-average grant date fair value of stock options during the three and six months ended June 25, 2016 was $7.89 and $8.29, respectively. Stock options were not granted during the three and six months ended June 27, 2015. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:



	Three Months Ended		Six Months Ended
	June 25, 2016		June 25, 2016
Expected dividend yield	0.0	%	0.0	%
Weighted average expected volatility	31.8	%	32.6	%
Weighted average risk-free interest rate	1.1	%	1.2	%
Expected holding period	4.00 years		4.00 years

Treasury Stock – As part of the Company’s equity incentive plans, the Company makes required tax payments on behalf of employees as their restricted shares vest. The Company withholds the number of vested shares having a value on the date of vesting equal to the minimum statutory tax obligation. The shares withheld are recorded as treasury shares. During the six months ended June 25, 2016, the Company purchased 32,700 shares in settlement of employees’ tax obligations for a total of $1.0 million. The Company accounts for treasury stock using the cost method. These shares are available to grant under the Company’s equity incentive plans.

7. Advertising Costs

The costs of advertising for online marketing arrangements, magazines, direct mail and radio are primarily expensed the first time the advertising takes place. Advertising expense was $6.3 million and $4.9 million for the three months ended June 25, 2016 and June 27, 2015, respectively, and $12.4 million and $11.5 million for the six months ended June 25, 2016 and June 27, 2015, respectively.

8. Net Income Per Share

The Company’s basic net income per share excludes the dilutive effect of stock options, unvested restricted shares, unvested performance share units and unvested restricted share units. It is based upon the weighted average number of common shares outstanding during the period divided into net income.

Diluted net income per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options, unvested restricted shares, unvested performance share units and unvested restricted share units are included as potential dilutive securities for the periods applicable, using the treasury stock method to the extent dilutive.

The components of the calculation of basic net income per common share and diluted net income per common share are as follows (in thousands except share and per share data):

Table of Contents



	Three Months Ended				Six Months Ended
	June 25, 2016		June 27, 2015		June 25, 2016		June 27, 2015
Numerator:
Net income	$	10,433	$	14,241	$	25,215	$	32,941
Denominator:
Basic weighted average common shares outstanding	23,763,934		29,230,046		24,283,135		29,363,823
Effect of dilutive securities:
Stock options	71,341		101,446		72,356		112,515
Restricted shares	97,167		122,635		114,892		183,610
Performance share units	5,086		—		2,627		—
Restricted share units	1,450		1,328		1,008		1,452
Diluted weighted average common shares outstanding	23,938,978		29,455,455		24,474,018		29,661,400
Basic net income per common share	$	0.44	$	0.49	$	1.04	$	1.12
Diluted net income per common share	$	0.44	$	0.48	$	1.03	$	1.11

No stock options or restricted shares have been excluded from the above calculation for the three months ended June 25, 2016. Stock options and restricted shares for the three months ended June 27, 2015 in the amount of 3,657 shares have been excluded from the above calculation as they were anti-dilutive. Stock options and restricted shares for the six months ended June 25, 2016 and June 27, 2015 in the amount of 5,080 shares and 6,836 shares, respectively, have been excluded from the above calculation as they were anti-dilutive.

The Company has the intent and ability to settle the principal portion of its Convertible Notes in cash, and as such, has applied the treasury stock method, which has resulted in the underlying convertible shares being anti-dilutive for the three and six months ended June 25, 2016 as the Company’s average stock price was less than the conversion price. Refer to Note 5. Credit Arrangements for additional information on the Convertible Notes.

9. Share Repurchase Programs

The Company’s board of directors approved share repurchase programs that enable the Company to purchase up to an aggregate of $300 million of its shares of common stock from time to time over three year periods ending on August 4, 2017, May 5, 2018 and November 22, 2018, respectively. As of June 25, 2016, 7,486,306 shares have been repurchased for a total of $254.9 million. The repurchase program does not obligate the Company to acquire any specific number of shares of its common stock and may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing such shares, the availability of alternative investment opportunities, liquidity, and other factors deemed appropriate. These factors may also affect the timing and amount of share repurchases.

During the three and six months ended June 25, 2016, the Company repurchased 304,943 and 1,739,484 shares, respectively, which were retired upon repurchase. The total purchase price during the three and six months ended June 25, 2016 was $8.7 million and $51.0 million, respectively, with an average repurchase price per share of $28.54 and $29.33, respectively. During the three and six months ended June 27, 2015, the Company repurchased 226,332 and 626,332 shares, respectively, which were retired upon repurchase. The total purchase price during the three and six months ended June 27, 2015 was $9.0 million and $25.5 million, respectively, with an average repurchase price per share of $39.76 and $40.78, respectively.

10. Legal Proceedings

The Company is party to various lawsuits arising from time to time in the normal course of business, some of which are covered by insurance. Although the impact of the final resolution of these matters on the Company's financial condition, results of operations or cash flows is not known, management does not believe that the resolution of these lawsuits will have a material adverse effect on the financial condition, results of operations or liquidity of the Company.

11. Segment Data

Table of Contents

The Company currently operates three business segments, retail, direct and manufacturing. The operating segments are segments of the Company for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and in assessing performance. The Company's management evaluates segment operating results based on several indicators. The primary key performance indicators are sales and operating income for each segment. The table below represents key financial information for each of the Company's business segments as well as corporate costs. The retail segment primarily includes the Company's retail stores. The retail segment generates revenue primarily through the sale of VMS products through Vitamin Shoppe and Super Supplements retail stores in the United States and Puerto Rico. The direct segment generates revenue through the sale of VMS products primarily through the Company's websites. The Company's websites offer customers online access to a full assortment of approximately 17,400 SKUs. The manufacturing segment supplies the retail and direct segments, along with various third parties, with finished products for sale. Corporate costs represent all other expenses not allocated to the retail, direct or manufacturing segments which include, but are not limited to: human resources, legal, retail management, direct management, finance, information technology, depreciation (primarily related to assets utilized by the retail and direct business segments as well as corporate assets) and amortization, and various other corporate level activity related expenses. Intercompany sales transactions are eliminated in consolidation.

The Company’s segments are designed to allocate resources internally and provide a framework to determine management responsibility. The accounting policies of the segments are consistent with those described in Note 2. Summary of Significant Accounting Policies in the Fiscal 2015 Form 10-K. The Company has allocated $165.3 million, $45.3 million and $32.6 million of its recorded goodwill to the retail, direct and manufacturing segments, respectively. The Company does not have identifiable assets separated by segment, with the exception of the identifiable assets of the manufacturing segment which were $88.5 million and $88.4 million as of June 25, 2016 and December 26, 2015, respectively. Capital expenditures for the manufacturing segment for the six months ended June 25, 2016 and June 27, 2015 were approximately $1.1 million and $2.3 million, respectively. At June 25, 2016 and December 26, 2015, long lived assets of the manufacturing segment were $59.8 million and $60.4 million, respectively. Depreciation and amortization expense, included in selling, general and administrative expenses, for the manufacturing segment during the three months ended June 25, 2016 and June 27, 2015 was approximately $0.4 million in both periods. Depreciation and amortization expense, included in selling, general and administrative expenses, for the manufacturing segment during the six months ended June 25, 2016 and June 27, 2015 was approximately $0.8 million and $0.7 million, respectively.

The following table contains key financial information of the Company’s business segments (in thousands):



	Three Months Ended						Six Months Ended
	June 25, 2016			June 27, 2015			June 25, 2016			June 27, 2015
Net sales:
Retail	$	288,290		$	278,200		$	576,302		$	566,183
Direct	32,773			30,346			68,625			65,190
Manufacturing	20,778			24,664			41,338			46,492
Segment net sales	341,841			333,210			686,265			677,865
Elimination of intersegment revenues	(9,124		)	(10,872		)	(16,774		)	(18,692		)
Net sales	$	332,717		$	322,338		$	669,491		$	659,173
Income (Loss) from operations:
Retail	$	50,469		$	51,613		$	107,132		$	107,672
Direct	4,500			5,587			9,686			10,652
Manufacturing (1)	(1,822		)	(1,510		)	(2,084		)	(1,211		)
Corporate costs (2)	(32,423		)	(32,126		)	(66,748		)	(62,594		)
Income from operations	$	20,724		$	23,564		$	47,986		$	54,519

(1) Manufacturing loss from operations for the three and six months ended June 27, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible.

(2) Corporate costs include (in thousands):

Table of Contents



	Three Months Ended				Six Months Ended
	June 25, 2016		June 27, 2015		June 25, 2016		June 27, 2015
Depreciation and amortization expenses	$	8,965	$	9,155	$	18,634	$	18,035
Canada stores closing costs (a)	1,864		—		2,963		—
Cost reduction project (b)	1,492		—		1,492		—
Super Supplements conversion costs (c)	—		—		1,275		—
Reinvention strategy costs (d)	—		—		541		—
Management realignment charges (e)	—		2,174		—		2,174
Integration costs (f)	—		410		—		770


(a)	Costs primarily include lease termination charges.


(b)	Outside consulting costs relating to a project to identify and implement cost reduction opportunities.


(c)	Costs primarily related to the closure of the Seattle distribution center.


(d)	The costs represent outside consultants fees in connection with the Company’s “reinvention strategy”.


(e)	Management realignment charges primarily consist of severance, sign-on bonuses, recruiting and relocation costs.


(f)	Represents integration costs related to the acquisition of Nutri-Force, consisting primarily of professional fees.

12. Fair Value of Financial Instruments

The fair value hierarchy requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows:


•	Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.


•	Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.


•	Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.

The Company’s financial instruments include cash, accounts receivable, accounts payable and its Revolving Credit Facility. The Company believes that the recorded values of these financial instruments approximate their fair values due to their nature and respective durations.

The following table contains information of the Company’s Convertible Notes (in thousands):



	June 25, 2016		December 26, 2015
Fair Value	$	116,896	$	119,784
Carrying Value	118,067		115,410

The fair value of the Convertible Notes was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of the Company’s Convertible Notes, when available, the Company’s stock price and interest rates based on similar debt issued by parties with credit ratings similar to the Company (Level 1 or 2).

Certain assets are measured at fair value on a non-recurring basis, that is, the assets are subject to fair value adjustments in certain circumstances such as when there is evidence of impairment. These measures of fair value, and related inputs, are considered Level 2 or 3 measures under the fair value hierarchy.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the condensed consolidated financial statements and notes thereto included as part of this quarterly report on Form 10-Q.

Table of Contents

Company Overview

We are a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products. As of June 25, 2016, we operated 771 stores in 45 states, the District of Columbia and Puerto Rico and also sold our products directly to consumers through the internet, primarily at www.vitaminshoppe.com. We market approximately 880 nationally recognized brands as well as our own brands, which include The Vitamin Shoppe®, BodyTech®, True Athlete®, Mytrition®, plnt®, ProBioCare®, Next Step® and Betancourt Nutrition®. We believe we offer one of the largest varieties of products among vitamin, mineral and supplement (“VMS”) retailers and continue to refine our assortment with approximately 7,400 stock keeping units ("SKUs") offered in our typical store and approximately 10,000 additional SKUs available through e-commerce. Our broad product offering enables us to provide our customers with a depth of selection of products that may not be readily available at other specialty retailers or mass merchants, such as discount stores, supermarkets, drugstores and wholesale clubs. We believe our product offering and emphasis on product knowledge and customer service helps us meet the needs of our target customer and serves as a foundation for enhancing customer loyalty.

During Fiscal 2015, the Company began development of a strategic plan focused on upgrading our customers’ experience across our retail and e-commerce channels, the “reinvention strategy”. We worked with outside consultants to analyze qualitative and quantitative information relevant to our customers’ experience. The reinvention strategy is focused on upgrading the customer experience to inspire our target customers with changes to curate our product assortment, opportunities to increase private brands penetration, enhancements to the in-store and digital experience, store layout, as well as changes to improve the effectiveness of our loyalty program. Such changes may result in a reduction of SKUs offered by the Company which could result in the recognition of related inventory charges in future periods. We expect to incur approximately $10.0 million of selling, general and administrative costs during Fiscal 2016 in connection with the reinvention strategy, of which approximately $6.0 million of such costs are expected to be on-going. These costs include additional internal resources, improvements to store network connectivity, and outside consultants. During the three and six months ended June 25, 2016, we incurred $2.9 million and $4.9 million, respectively, of costs in connection with the reinvention strategy. The Company is in the process of testing several initiatives and expects to realize improved financial results from the reinvention strategy beginning in Fiscal 2017. In addition, we have engaged a consulting firm in Fiscal 2016 to identify other efficiencies and cost reduction opportunities focusing on product sourcing, store operations and corporate expenses. During the second quarter of Fiscal 2016, we incurred $1.5 million of costs in connection with identifying other efficiencies and cost reduction opportunities and expect to incur approximately $3.0 million during the second half of Fiscal 2016. As a result of this cost reduction project, we have identified savings potential with an additional estimated value of at least $10.0 million on an annualized basis.

In Fiscal 2015, we also performed a review of certain business operations. As part of this review, we implemented changes to the product assortment and supply chain operations of Super Supplements to more closely align Super Supplements with current processes and assortments in the Vitamin Shoppe retail stores. As a result, net costs of $1.0 million were incurred during the first quarter of Fiscal 2016. Annual cost savings resulting from these actions are estimated to be $1 million to $2 million. In addition, the Company decided to cease operations in Canada, closing one store in the first quarter and closing the remaining two stores in the second quarter of Fiscal 2016. As a result, during the three and six months ended June 25, 2016, net costs of $1.9 million and $2.8 million, respectively, were incurred in connection with ceasing operations in Canada and the annual cost savings are estimated to be approximately $1.0 million. Costs for these two initiatives include lease liabilities, markdown charges on inventory and employee severance.

Since the acquisition in Fiscal 2014, Nutri-Force has experienced disruption in its ability to optimize production capacity, volatility in sales performance, and correspondingly has experienced lower service levels to customers. We continue to take steps to improve the operations at Nutri-Force, including improvements in operating efficiencies and the ability to transition additional Vitamin Shoppe branded products. We believe such disruptions should not impact the long-term opportunity from the Nutri-Force acquisition. However, based upon the operating results of Nutri-Force during the three months ended June 25, 2016, we concluded that an impairment trigger occurred for the manufacturing reporting unit and therefore an impairment test was performed. A discounted cash flow model was prepared using the most recent internal forecast, including an estimate of long-term future growth rates and a discount rate determined by management to be commensurate with the risk inherent in this forecast. The results of this analysis determined the fair value of the manufacturing reporting unit exceeded its carrying value, and as a result, we concluded the goodwill assigned to the reporting unit was not impaired. However, the fair value of the manufacturing reporting unit exceeded its carrying value by approximately 5%, which is not considered to be a substantial excess over the carrying value. Should financial performance not improve or if growth expectations are not achieved, estimates of future cash flows may be insufficient to support the carrying value of goodwill of $32.6 million assigned to Nutri-Force as of June 25, 2016, which may result in impairment charges in future periods.

Highlights for the Second Quarter of Fiscal 2016

Table of Contents


•	Net sales increased 3.2% compared to the same period of the prior year


•	Total comparable net sales increased 1.6%


•	Comparable store net sales increased 0.8%


•	Comparable e-commerce net sales increased 9.4%


•	Fully diluted earnings per share of $0.44

Outlook for Fiscal 2016

Management expects the following for Fiscal 2016, on a 53-week basis:


•	Total comparable net sales growth expected to be flat to slightly negative


•	To open approximately 30 new stores


•	Capital expenditures of approximately $40 million

Segment Information

We operate through three business segments: retail, which includes Vitamin Shoppe and Super Supplements retail store formats, direct, which consists of our e-commerce and catalog formats, and manufacturing, which consists of the Nutri-Force manufacturing operations.

Retail. Through our retail store formats, we believe we differentiate ourselves in the VMS industry, which has been successful across geographic and demographic markets. What makes us unique is our broad selection of VMS products and our stores are staffed with trained and knowledgeable employees, who we refer to as Health Enthusiasts®, and who are able to inform our customers about product features and assist in product selection.

Direct. We also sell our products directly to consumers through the internet, primarily at www.vitaminshoppe.com. Our e-commerce sites complement our in-store experience by extending our retail product offerings with approximately 10,000 additional SKUs that are not available in our stores and enable us to access customers outside our retail markets and those who prefer to shop online.

Manufacturing. Through Nutri-Force, we provide custom manufacturing and private labeling of VMS products and develop and market our own branded products for both sales to third parties and for the VSI product assortment.

Trends and Other Factors Affecting Our Business

Our performance is affected by industry trends including, among others, demographic, health and lifestyle preferences, as well as other factors, such as industry media coverage and governmental actions. For example, our industry is subject to potential regulatory activity and other legal matters that could affect the credibility of a given product or category of products. Consumer trends, the overall impact on consumer spending, which may be affected heavily by current economic conditions, and limited product innovation and introductions in the VMS industry can dramatically affect purchasing patterns. Even though our business model allows us to respond to changing industry trends by introducing new products and adjusting our product mix and sales incentives, such actions may not offset adverse trends. Additionally, our performance is affected by competitive trends such as the entry and expansion of competitors, changes in promotional strategies or expansion of product assortment by various competitors.

Our historical results have also been significantly influenced by our new store openings. Since the beginning of Fiscal 2014, we have opened 129 stores and as of June 25, 2016 operate 771 stores located in 45 states, the District of Columbia and Puerto Rico. In Fiscal 2016, we have reduced the number of new store openings as we continue to evaluate and implement our reinvention strategy. We plan to open approximately 30 new stores in Fiscal 2016.

New stores have typically required approximately four to five years to mature, generating lower store level sales in the initial years than our mature stores. As a result, new stores generally have a negative impact on our overall operating margin. In addition, our new stores since the beginning of Fiscal 2013 are approximately 2,900 square feet compared to the average of our total store portfolio of approximately 3,500 square feet. Additionally, stores opened in new markets have lower brand awareness compared to stores in existing markets, and as a result initially experience a lower sales volume than stores opened in existing markets. As these stores mature, we expect them to contribute positively to our operating results.

Table of Contents

In Fiscal 2015, the Company began implementation of a new warehouse management system application (“WMS”) at its Ashland, Virginia distribution center in order to realize further productivity improvements and functionality. Implementation of the new WMS is expected to be completed by the fourth quarter of Fiscal 2016. In addition, we are evaluating alternatives for establishing distribution capabilities in the western U.S.

Critical Accounting Policies

Our significant accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in our financial statements in the Fiscal 2015 Form 10-K. A discussion of our critical accounting policies and estimates is included in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Fiscal 2015 Form 10-K. Management has discussed the development and selection of these policies with the Audit Committee of our Board of Directors, and the Audit Committee of our Board of Directors has reviewed the disclosures relating to them. Management believes there have been no material changes to the critical accounting policies or estimates reported in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of the Fiscal 2015 Form 10-K.

General Definitions for Operating Results

Net Sales consist of sales, net of sales returns, deferred sales, customer incentives and a provision for estimated future returns, from comparable and non-comparable sales. Total comparable net sales include sales generated by retail stores after 410 days of operation and e-commerce sales. Sales to third parties of manufactured products generated by Nutri-Force are considered non-comparable sales.

Cost of goods sold includes the cost of inventory sold, costs of warehousing, distribution, manufacturing and store occupancy costs and excludes depreciation and amortization related to the retail and direct segments that is included within selling, general and administrative expenses. Warehousing, distribution and manufacturing costs, which are capitalized into inventory and then expensed as merchandise is sold, include freight to transfer merchandise, costs associated with our buying department, distribution facilities and manufacturing overhead. Store occupancy costs include rent, common area maintenance, real estate taxes and utilities.

Gross profit is net sales minus cost of goods sold.

Selling, general and administrative expenses consist of depreciation and amortization of fixed and intangible assets, operating payroll and related benefits, advertising and promotion expense, and other selling, general and administrative expenses.

Income from operations consists of gross profit minus selling, general and administrative expenses.

Interest expense, net includes interest on our Revolving Credit Facility and Convertible Notes, letters of credit fees, interest on our capital leases, as well as amortization of financing costs, reduced by interest income earned from highly liquid investments (investments purchased with an original maturity of three months or less).

Key Performance Indicators and Statistics

We use a number of key indicators of financial condition and operating results to evaluate the performance of our business, including the following (in thousands):



	Three Months Ended						Six Months Ended
	June 25, 2016			June 27, 2015			June 25, 2016			June 27, 2015
Net sales	$	332,717		$	322,338		$	669,491		$	659,173
Increase (Decrease) in total comparable net sales (1)	1.6		%	(1.1		)%	(0.2		)%	0.1		%
Increase (Decrease) in comparable store net sales	0.8		%	(0.6		)%	(0.9		)%	0.5		%
Increase (Decrease) in e-commerce comparable net sales	9.4		%	(6.0		)%	6.4		%	(3.3		)%
Gross profit as a percent of net sales	32.4		%	33.6		%	33.5		%	33.8		%
Income from operations	$	20,724		$	23,564		$	47,986		$	54,519


(1)	Total comparable net sales are comprised of comparable retail store sales and e-commerce sales.

Table of Contents

The following table shows the growth in our network of stores during the three and six months ended June 25, 2016 and June 27, 2015:



	Three Months Ended				Six Months Ended
	June 25, 2016		June 27, 2015		June 25, 2016		June 27, 2015
Store Data:
Stores open at beginning of period	766		725		758		717
Stores opened	9		13		18		24
Stores closed	(4	)	(4	)	(5	)	(7	)
Stores open at end of period	771		734		771		734
Total retail square footage at end of period (in thousands)	2,701		2,595		2,701		2,595
Average store square footage at end of period	3,503		3,535		3,503		3,535

Three Months Ended June 25, 2016 Compared to Three Months Ended June 27, 2015

The information presented below is for the three months ended June 25, 2016 and June 27, 2015 and was derived from our condensed consolidated financial statements, which, in the opinion of management, include all adjustments necessary for a fair presentation of our financial position and operating results for such periods and as of such dates.

The following tables summarize our results of operations for the three months ended June 25, 2016 and June 27, 2015 (in thousands):



	Three Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Net sales	$	332,717		$	322,338		$	10,379		3.2	%
Cost of goods sold	224,893			214,078			10,815			5.1	%
Cost of goods sold as % of net sales	67.6		%	66.4		%
Gross profit	107,824			108,260			(436		)	(0.4	)%
Gross profit as % of net sales	32.4		%	33.6		%
Selling, general and administrative expenses	87,100			84,696			2,404			2.8	%
SG&A expenses as % of net sales	26.2		%	26.3		%
Income from operations	20,724			23,564			(2,840		)	(12.1	)%
Income from operations as % of net sales	6.2		%	7.3		%
Interest expense, net	2,352			179			2,173			1,214.0	%
Income before provision for income taxes	18,372			23,385			(5,013		)	(21.4	)%
Provision for income taxes	7,939			9,144			(1,205		)	(13.2	)%
Net income	$	10,433		$	14,241		$	(3,808	)	(26.7	)%

Net Sales

Net sales increased 3.2% as a result of an increase in our total comparable net sales of $5.0 million, or 1.6% and an increase in our total non-comparable net sales of $7.5 million offset by a decrease in Nutri-Force net sales of $2.1 million to third parties. Sales increased $7.5 million in the Vitamins, Minerals and Herbs category and increased $4.4 million in the Specialty Supplements category, which includes whole foods, cleansing and digestive supplements.

Net sales for our three business segments, as well as a discussion of the changes in each segment's net sales from the comparable prior year period, are provided below (in thousands):

Table of Contents



	Three Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Net Sales:
Retail (a)	$	288,290		$	278,200		$	10,090		3.6	%
Direct (b)	32,773			30,346			2,427			8.0	%
Manufacturing (c)	20,778			24,664			(3,886		)	(15.8	)%
Segment net sales	341,841			333,210			8,631			2.6	%
Elimination of intersegment revenues	(9,124		)	(10,872		)	1,748			(16.1	)%
Total net sales	$	332,717		$	322,338		$	10,379		3.2	%


(a)	The change in retail sales resulted from an increase in comparable store sales of $2.2 million, or 0.8% and an increase in non-comparable store sales of $7.9 million. The increase in comparable store sales was primarily driven by higher customer traffic resulting primarily from promotional activities and changes in the loyalty program.


(b)	Direct sales increased primarily due to an increase in e-commerce sales of 9.4% partially offset by a decrease in catalog sales. The increase in e-commerce sales was primarily due to effective customer acquisition, promotional activities and changes in the loyalty program.


(c)	Manufacturing sales reflect a decrease of $2.1 million in product manufactured for third parties and a decrease of $1.7 million in product manufactured for the Vitamin Shoppe assortment.

Cost of Goods Sold

Cost of goods sold includes product, warehouse, distribution, manufacturing and occupancy costs. As a percentage of net sales, cost of goods sold increased primarily due to a 0.7% decline in product margin resulting primarily from an increase in promotional pricing in response to increased promotions by competitors and loyalty program redemptions, an increase of 0.5% due to Nutri-Force and an increase of 0.1% related to occupancy costs partially offset by 0.1% due to supply chain costs.

Selling, General and Administrative Expenses



	Three Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
SG&A Expenses (in thousands):
Store Payroll and Benefits (a)	$	34,020		$	32,214		$	1,806		5.6	%
Store Payroll & benefits as % of net sales	10.2		%	10.0		%
Advertising and Promotion (b)	6,322			4,938			1,384			28.0	%
Advertising & promotion as % of net sales	1.9		%	1.5		%
Other SG&A (c)	46,758			47,544			(786		)	(1.7	)%
Other SG&A as % of net sales	14.1		%	14.7		%
Total SG&A Expenses	$	87,100		$	84,696		$	2,404		2.8	%


(a)	Store payroll and benefits increased primarily due to the increase in head count to operate new stores and an increase in the average wage rates.


(b)	Advertising and promotion increased due to higher retail expenditures and digital advertising partially offset by lower expenditures related to Nutri-Force.

(c)

Other SG&A expenses for the three month period ended June 25, 2016 includes costs related to the closing of the Canada stores of $1.9 million and consulting costs in connection with identifying efficiencies and cost reduction opportunities of $1.5 million. Other SG&A expenses for the three month period ended June 27, 2015 includes management realignment charges of $2.2 million, a charge for accounts receivable for one wholesale customer which were deemed uncollectible of $1.4 million and integration costs related to the acquisition of Nutri-Force of $0.4 million.

Table of Contents

Income from Operations

Operating income (loss) for our three business segments are provided below (in thousands):



	Three Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Income (Loss) from operations:
Retail (a)	$	50,469		$	51,613		$	(1,144	)	(2.2	)%
% of net sales	17.5		%	18.6		%
Direct (b)	4,500			5,587			(1,087		)	(19.5	)%
% of net sales	13.7		%	18.4		%
Manufacturing (c)	(1,822		)	(1,510		)	(312		)	20.7	%
% of net sales	(8.8		)%	(6.1		)%
Corporate costs (d)	(32,423		)	(32,126		)	(297		)	0.9	%
% of net sales	(9.7		)%	(10.0		)%
Income from operations	$	20,724		$	23,564		$	(2,840	)	(12.1	)%


(a)	The decrease in retail income from operations as a rate of sales is due to a 0.5% increase in advertising and promotion, a 0.2% decrease in gross margin resulting from an increase in promotional pricing, 0.2% related to an increase in occupancy costs and 0.2% from store payroll and benefits costs.


(b)	The decrease in direct income from operations is primarily due to a reduction in margin resulting from an increase in promotional pricing and delivery expense.


(c)	The decrease in manufacturing income from operations was primarily due to lower sales volume. The three month period ended June 27, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible.

(d)

Corporate costs for the three month period ended June 25, 2016 include costs related to the closing of the Canada stores of $1.9 million and consulting costs in connection with identifying efficiencies and cost reduction opportunities of $1.5 million. Corporate costs for the three month period ended June 27, 2015 include management realignment charges of $2.2 million and integration costs related to the acquisition of Nutri-Force of $0.4 million.

Interest Expense, Net

The increase in interest expense, net of $2.2 million is primarily due to interest expense on our Convertible Notes, which includes the coupon interest, amortization of the debt discount and the amortization of deferred financing fees.

Provision for Income Taxes

The effective tax rate for the three months ended June 25, 2016 was 43.2%, compared to 39.1% for the three months ended June 27, 2015. The change in the effective tax rate is primarily due to charges incurred in Canada related to the closing of retail stores which do not result in tax benefits to the Company’s consolidated results.

Six Months Ended June 25, 2016 Compared to Six Months Ended June 27, 2015

The information presented below is for the six months ended June 25, 2016 and June 27, 2015 and was derived from our condensed consolidated financial statements, which, in the opinion of management, include all adjustments necessary for a fair presentation of our financial position and operating results for such periods and as of such dates.

The following tables summarize our results of operations for the six months ended June 25, 2016 and June 27, 2015 (in thousands):

Table of Contents



	Six Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Net sales	$	669,491		$	659,173		$	10,318		1.6	%
Cost of goods sold	445,420			436,264			9,156			2.1	%
Cost of goods sold as % of net sales	66.5		%	66.2		%
Gross profit	224,071			222,909			1,162			0.5	%
Gross profit as % of net sales	33.5		%	33.8		%
Selling, general and administrative expenses	176,085			168,390			7,695			4.6	%
SG&A expenses as % of net sales	26.3		%	25.5		%
Income from operations	47,986			54,519			(6,533		)	(12.0	)%
Income from operations as % of net sales	7.2		%	8.3		%
Interest expense, net	4,614			343			4,271			1,245.2	%
Income before provision for income taxes	43,372			54,176			(10,804		)	(19.9	)%
Provision for income taxes	18,157			21,235			(3,078		)	(14.5	)%
Net income	$	25,215		$	32,941		$	(7,726	)	(23.5	)%

Net Sales

Net sales increased 1.6% as a result of an increase in our total non-comparable net sales of $14.5 million offset by a decrease in our total comparable net sales of $1.0 million, or 0.2% and a decrease in Nutri-Force net sales of $3.2 million to third parties. Sales increased $12.2 million in the Vitamins, Minerals and Herbs category and decreased $7.4 million in the Sports Nutrition category.

Net sales for our three business segments, as well as a discussion of the changes in each segment's net sales from the comparable prior year period, are provided below (in thousands):



	Six Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Net Sales:
Retail (a)	$	576,302		$	566,183		$	10,119		1.8	%
Direct (b)	68,625			65,190			3,435			5.3	%
Manufacturing (c)	41,338			46,492			(5,154		)	(11.1	)%
Segment net sales	686,265			677,865			8,400			1.2	%
Elimination of intersegment revenues	(16,774		)	(18,692		)	1,918			(10.3	)%
Total net sales	$	669,491		$	659,173		$	10,318		1.6	%


(a)	The change in retail sales resulted from an increase in non-comparable store sales of $15.2 million offset by a decrease in comparable store sales of $5.1 million, or 0.9%. The decrease in comparable store sales was primarily driven by lower customer traffic.


(b)	Direct sales increased primarily due to an increase in e-commerce sales of 6.4% partially offset by a decrease in catalog sales. The increase in e-commerce sales was primarily due to effective customer acquisition and promotional activities.


(c)	Manufacturing sales reflect a decrease of $3.2 million in product manufactured for third parties and a decrease of $1.9 million in product manufactured for the Vitamin Shoppe assortment.

Cost of Goods Sold

Cost of goods sold includes product, warehouse, distribution, manufacturing and occupancy costs. As a percentage of net sales, cost of goods sold increased primarily due to 0.3% related to occupancy costs and 0.2% resulting from Nutri-Force partially offset by 0.3% resulting from category mix and higher private brands penetration.

Table of Contents

Selling, General and Administrative Expenses



	Six Months Ended
	June 25, 2016			June 27, 2015			$ Change		% Change
SG&A Expenses (in thousands):
Store Payroll and Benefits (a)	$	67,865		$	64,208		$	3,657	5.7	%
Store Payroll & benefits as % of net sales	10.1		%	9.7		%
Advertising and Promotion (b)	12,394			11,470			924		8.1	%
Advertising & promotion as % of net sales	1.9		%	1.7		%
Other SG&A (c)	95,826			92,712			3,114		3.4	%
Other SG&A as % of net sales	14.3		%	14.1		%
Total SG&A Expenses	$	176,085		$	168,390		$	7,695	4.6	%


(a)	Store payroll and benefits increased primarily due to the increase in head count to operate new stores and an increase in the average wage rates.


(b)	Advertising and promotion increased due to higher retail expenditures and digital advertising partially offset by lower expenditures related to Nutri-Force.

(c)

Other SG&A expenses for the six month period ended June 25, 2016 includes costs related to the closing of the Canada stores of $3.0 million, consulting costs in connection with identifying efficiencies and cost reduction opportunities of $1.5 million, Super Supplements conversion costs of $1.3 million and consultants fees in connection with the Company's "reinvention strategy" of $0.5 million. Other SG&A expenses for the six month period ended June 27, 2015 includes management realignment charges of $2.2 million, a charge for accounts receivable for one wholesale customer which were deemed uncollectible of $1.4 million and integration costs related to the acquisition of Nutri-Force of $0.8 million.

Income from Operations

Operating income (loss) for our three business segments are provided below (in thousands):



	Six Months Ended
	June 25, 2016			June 27, 2015			$ Change			% Change
Income (Loss) from operations:
Retail (a)	$	107,132		$	107,672		$	(540	)	(0.5	)%
% of net sales	18.6		%	19.0		%
Direct (b)	9,686			10,652			(966		)	(9.1	)%
% of net sales	14.1		%	16.3		%
Manufacturing (c)	(2,084		)	(1,211		)	(873		)	72.1	%
% of net sales	(5.0		)%	(2.6		)%
Corporate costs (d)	(66,748		)	(62,594		)	(4,154		)	6.6	%
% of net sales	(10.0		)%	(9.5		)%
Income from operations	$	47,986		$	54,519		$	(6,533	)	(12.0	)%


(a)	The decrease in retail income from operations as a rate of sales is due to 0.5% from store payroll and benefits costs, 0.4% related to occupancy costs and 0.3% resulting from other selling, general and administrative expenses partially offset by a 0.8% increase in gross margin resulting from category mix and higher private brands penetration.


(b)	The decrease in direct income from operations is primarily due to a reduction in margin resulting from category mix, and an increase in promotional pricing and delivery expense.

Table of Contents


(c)	The decrease in manufacturing income from operations was primarily due to lower sales volume. The six month period ended June 27, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible.

(d)

Corporate costs for the six month period ended June 25, 2016 include costs related to the closing of the Canada stores of $3.0 million, consulting costs in connection with identifying efficiencies and cost reduction opportunities of $1.5 million, Super Supplements conversion costs of $1.3 million and consultants fees in connection with the Company's "reinvention strategy" of $0.5 million. Corporate costs for the six month period ended June 27, 2015 include management realignment charges of $2.2 million and integration costs related to the acquisition of Nutri-Force of $0.8 million.

Interest Expense, Net

The increase in interest expense, net of $4.3 million is primarily due to interest expense on our Convertible Notes, which includes the coupon interest, amortization of the debt discount and the amortization of deferred financing fees.

Provision for Income Taxes

The effective tax rate for the six months ended June 25, 2016 was 41.9%, compared to 39.2% for the six months ended June 27, 2015. The change in the effective tax rate is primarily due to charges incurred in Canada related to the closing of retail stores which do not result in tax benefits to the Company’s consolidated results.

Key Indicators of Liquidity and Capital Resources

The following table provides key indicators of our liquidity and capital resources (in thousands):



	As of
	June 25, 2016		December 26, 2015
Balance Sheet Data:
Cash and cash equivalents	$	1,992	$	15,104
Working capital (a)	138,927		157,089
Total assets	740,532		748,691
Total debt (b)	133,138		123,525

(a) Working capital is total current assets minus total current liabilities.

(b) Total debt includes the outstanding balance on the Company's Revolving Credit Facility, the net balance of its Convertible Notes and its capital lease obligations.



	Six Months Ended
	June 25, 2016			June 27, 2015
Other Information:
Depreciation and amortization of fixed and intangible assets	$	19,440		$	18,750
Cash Flows Provided By (Used In):
Operating activities	$	54,941		$	31,771
Investing activities	(21,176		)	(20,346		)
Financing activities	(46,930		)	(20,365		)
Effect of exchange rate changes on cash and cash equivalents	53			103
Net decrease in cash and cash equivalents	$	(13,112	)	$	(8,837	)

Liquidity and Capital Resources

Our primary uses of cash have been to fund working capital, operating expenses and capital expenditures related primarily to the build-out of new stores, the remodeling of existing stores and information technology investments as well as to

Table of Contents

repurchase shares of our common stock. Historically, we have financed our requirements predominately through internally generated cash flow, supplemented with short-term financing. In Fiscal 2015, we issued $143.8 million of Convertible Notes to fund the repurchase of shares of our common stock. Refer to Note 5., “Credit Arrangements”, to our condensed consolidated financial statements for additional information. We believe that the cash generated by operations and cash and cash equivalents, together with the borrowing availability under our Revolving Credit Facility, will be sufficient to meet our working capital needs for the next twelve months, our store growth plans, costs and investments related to our reinvention strategy, systems development, store improvements and interest payments on the Convertible Notes, as well as the repurchase of shares of our common stock from time to time.

We purchased $51.0 million of common stock under our $300.0 million share repurchase programs during the six months ended June 25, 2016. Refer to Note 9., “Share Repurchase Programs”, to our condensed consolidated financial statements for additional information. During Fiscal 2016 we plan to spend approximately $40 million in capital expenditures, including costs for building new stores, remodeling existing stores and information technology and investments resulting from our reinvention strategy. Of the total capital expenditures projected for Fiscal 2016, we have invested $21.0 million during the six months ended June 25, 2016. We plan to open approximately 30 new stores in Fiscal 2016, of which we have opened 18 stores and closed 5 stores as of June 25, 2016. Our working capital requirements for merchandise inventory will continue to increase as we continue to open additional stores. Currently, our practice is to establish an inventory level of approximately $145,000 at cost for each of our stores, the cost of which is partially offset by vendor incentive and allowance programs. Additionally, 30 day payment terms have been extended to us by some of our suppliers allowing us to effectively manage our inventory and working capital.

The Company is subject to concentrations of credit risk associated with cash and cash equivalents, and at times holds cash balances in excess of Federal Deposit Insurance Corporation limits. Currently, the Company’s cash management practice is to hold cash balances in quality institutions and invest in highly liquid and secure investments.

We were in compliance with all covenants relating to our Revolving Credit Facility and Convertible Notes as of June 25, 2016. We expect to be in compliance with these same debt covenants during the remainder of Fiscal 2016 as well.

Cash Provided by Operating Activities

Net cash provided by operating activities was $54.9 million for the six months ended June 25, 2016 as compared to $31.8 million for the six months ended June 27, 2015. The $23.2 million increase in cash flows from operating activities is primarily due to an increase in inventory purchases for the six months ended June 27, 2015 related primarily to the transition of Vitamin Shoppe production of private brands to Nutri-Force and the opening of new stores.

Cash Used in Investing Activities

Net cash used in investing activities was $21.2 million during the six months ended June 25, 2016 as compared to $20.3 million during the six months ended June 27, 2015. Capital expenditures during the six months ended June 25, 2016 and June 27, 2015 were used primarily for the build-out of new stores, the remodeling of existing stores and information technology investments. The Company opened 18 new stores during the six months ended June 25, 2016 as compared to 24 new stores during the six months ended June 27, 2015.

Cash Used in Financing Activities

Net cash used in financing activities was $46.9 million for the six months ended June 25, 2016, as compared to $20.4 million for the six months ended June 27, 2015. The $26.6 million increase in cash used in financing activities is primarily due to an increase in purchases of common stock under the Company's share repurchase programs.

Revolving Credit Facility

The terms of our Revolving Credit Facility extend through October 11, 2018, and allow the Company to borrow up to $90.0 million, subject to the terms of the facility, with a Company option to increase the facility up to a total of $150.0 million. For information regarding the terms of our Revolving Credit Facility, refer to Note 5., “Credit Arrangements” in the Notes to Condensed Consolidated Financial Statements (unaudited). As of June 25, 2016, the Company had $15.0 million of borrowings outstanding on its Revolving Credit Facility. The largest amount outstanding during the six months ended June 25, 2016 and June 27, 2015 was $21.0 million and $27.0 million, respectively. The unused available line of credit under the Revolving Credit Facility at June 25, 2016 was $72.1 million.

Convertible Notes

On December 9, 2015, the Company issued $143.8 million of its 2.25% Convertible Notes. The Convertible Notes are

Table of Contents

senior unsecured obligations of VSI. Interest is payable on the Convertible Notes on June 1 and December 1 of each year, commencing on June 1, 2016 until their maturity date of December 1, 2020. For additional information regarding the terms of our Convertible Notes, refer to Note 5., "Credit Arrangements", to our condensed consolidated financial statements.

Contractual Obligations and Commercial Commitments

As of June 25, 2016, there have been no material changes with respect to our contractual obligations since December 26, 2015. For additional information, see Contractual Obligations and Commercial Commitments under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, in the Fiscal 2015 Form 10-K.

Off-Balance Sheet Arrangements

We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt or operating our business. We do not have any off-balance sheet arrangements or relationships with entities that are not consolidated into our financial statements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources. The Company has commitments for its operating leases, primarily related to its stores, distribution centers, as well as its manufacturing and corporate facilities, which are not reflected on our balance sheet. For additional information, see Contractual Obligations and Commercial Commitments under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, in the Fiscal 2015 10-K.

Effects of Inflation

We do not believe that our sales or operating results have been materially affected by inflation during the periods presented in our financial statements. During the six months ended June 25, 2016, retail price inflation was approximately 1%. We anticipate retail inflation to be approximately 1% for Fiscal 2016. Additionally, we may experience increased cost pressure from our suppliers which could have an adverse effect on our gross profit results in the future.

Recent Accounting Pronouncements

Except as discussed in Note 1., “Basis of Presentation” in the Notes to the Condensed Consolidated Financial Statements (unaudited), the Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on its results of operations, financial condition, or cash flows, based on current information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

The Company’s market risks relate primarily to changes in interest rates. Market risk represents the risk of changes in the value of market risk sensitive instruments caused by fluctuations in interest rates and commodity prices. Changes in these factors could cause fluctuations in the results of our operations and cash flows.

Our Revolving Credit Facility carries a floating interest rate and, therefore, our statements of income and our cash flows are exposed to changes in interest rates. As of June 25, 2016, there was $15.0 million of borrowings outstanding on our Revolving Credit Facility. At June 25, 2016, a hypothetical 10% change in the floating interest rate would have a de minimis impact on our consolidated financial statements.

Our Convertible Notes carry a fixed interest rate and, therefore, have no market risk.

Item 4. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, who are our principal executive officer and principal financial officer, respectively, of the design and operation of our disclosure controls and procedures as such term is defined in Rules l3a-15(e) and l5d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of June 25, 2016, pursuant to

Table of Contents

Exchange Act Rules 13a-l5 and 15d-15. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of June 25, 2016.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the quarter ended June 25, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including the Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

For a more detailed explanation of the factors affecting our business, please refer to the Risk Factors section in the Fiscal 2015 Form 10-K. There has not been a material change to the risk factors set forth in the Fiscal 2015 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table summarizes the Company’s purchases of shares of common stock during the quarter ended June 25, 2016:



Period	Total Number of Shares (or Units) Purchased (1)	Average Price Paid per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (2)	Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs (in thousands)
March 27, 2016 through April 23, 2016	23,216	$	29.40	—	$	53,772
April 24, 2016 through May 21, 2016	187,148	$	28.03	186,295	$	48,550
May 22, 2016 through June 25, 2016	120,314	$	29.38	118,648	$	45,068
Totals	330,678			304,943


(1)	Includes 25,735 shares withheld to cover required tax payments on behalf of employees as their restricted shares vest.


(2)	On August 5, 2014, May 6, 2015 and November 23, 2015, the Company’s board of directors approved share repurchase programs that enable the Company to purchase up to an aggregate of $300 million of its shares of common stock from time to time over three year periods ending on August 4, 2017, May 5, 2018 and November 22, 2018, respectively.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Table of Contents

Item 6. Exhibits

Exhibit

No. Description


3.1	Amended and Restated Certificate of Incorporation of Vitamin Shoppe, Inc. (Incorporated by reference to Exhibit 3.1 in our Current Report on Form 8-K filed on June 10, 2016 (File No. 001-34507))


3.2	Fourth Amended and Restated By-laws of Vitamin Shoppe, Inc. (Incorporated by reference to Exhibit 3.2 in our Annual Report on Form 10-K filed on February 23, 2016 (File No. 001-34507))


10.01	Offer Letter, dated as of June 6, 2016, among Vitamin Shoppe, Inc., Vitamin Shoppe Industries Inc. and Jason Reiser (Incorporated by reference to Exhibit 10.1 in our Current Report on Form 8-K filed on June 16, 2016 (File No. 001-34507))*


31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.


31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.


32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Chief Executive Officer.


32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Chief Financial Officer.

101.1

The following financial information from the Company’s Quarterly Report on Form 10-Q, for the period ended June 25, 2016, formatted in eXtensible Business Reporting Language: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements

* Management contract or compensation plan or arrangement.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August 3, 2016.




VITAMIN SHOPPE, INC.

By:		/s/ Brenda Galgano
		Brenda Galgano
		EVP and Chief Financial Officer

Table of Contents

INDEX TO EXHIBITS

Exhibit

No. Description


3.1	Amended and Restated Certificate of Incorporation of Vitamin Shoppe, Inc. (Incorporated by reference to Exhibit 3.1 in our Current Report on Form 8-K filed on June 10, 2016 (File No. 001-34507))


3.2	Fourth Amended and Restated By-laws of Vitamin Shoppe, Inc. (Incorporated by reference to Exhibit 3.2 in our Annual Report on Form 10-K filed on February 23, 2016 (File No. 001-34507))


10.01	Offer Letter, dated as of June 6, 2016, among Vitamin Shoppe, Inc., Vitamin Shoppe Industries Inc. and Jason Reiser (Incorporated by reference to Exhibit 10.1 in our Current Report on Form 8-K filed on June 16, 2016 (File No. 001-34507))*


31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.


31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.


32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Chief Executive Officer.


32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Chief Financial Officer.

101.1

* Management contract or compensation plan or arrangement.

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if smaller reporting company)

Smaller reporting company